Clinical trial
A Randomised, Open-label, Parallel-group, Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens (Co-administration), of AmBisome, Paromomycin and Miltefosine in Visceral Leishmaniasis (VL)
NCT00523965 is registered in ClinicalTrials.gov with Banaras Hindu University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Open-label, Parallel-group, Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens (Co-administration), of AmBisome, Paromomycin and Miltefosine in Visceral Leishmaniasis (VL)
- Lead sponsor
- Banaras Hindu University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- February 28, 2010
- Enrollment
- 624 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.